425: Strive, Semler Scientific Announce Merger Plans

Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination, as communicated by Strive Board Member Pierre Rochard.

Summary

• Strive, Inc. and Semler Scientific, Inc. are engaged in a proposed business combination.
• The communication regarding the proposed transaction was reposted on X.com by Pierre Rochard, a Board Member of Strive, Inc., on September 25, 2025.
• The transaction involves Strive issuing additional shares of its Class A common stock.
• A Registration Statement on Form S-4, which will include an Information Statement/Proxy Statement/Prospectus, is intended to be filed with the SEC.
• Semler Scientific stockholders will be sent a definitive Information Statement/Proxy Statement/Prospectus to seek their approval of the proposed transaction.

Sentiment

Score: 6

Explanation: The filing announces a significant corporate event (a proposed merger) but is primarily a procedural and risk disclosure document. The tone is neutral and legally cautious, with extensive forward-looking statements and risks outlined, which is standard for such filings. The event itself is material, but the document's content is not inherently positive or negative beyond the announcement of the transaction and its associated risks.

Positives

• The proposed transaction is expected to yield strategic and financial benefits.
• Anticipated positive impact on the combined company's future financial performance.
• Expected realization of cost savings and strategic gains from the combination.

Negatives

• The proposed transaction may divert management's attention from ongoing business operations and opportunities.
• Strive's issuance of additional shares of its Class A common stock in connection with the transaction will cause dilution.
• Potential for adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price may occur before the closing of the transaction.

Risks

• The merger agreement between Strive and Semler Scientific could be terminated due to various events, changes, or circumstances.
• The proposed transaction may not close when expected or at all if conditions to closing are not received or satisfied on a timely basis.
• Legal proceedings may be instituted against Strive, Semler Scientific, or the combined company, impacting the transaction.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all, partly due to risks associated with Bitcoin and other digital assets, and implementation of Bitcoin treasury strategies.
• Integration of the two companies may prove more difficult, time-consuming, or costly than initially expected.
• The proposed transaction could be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities is a risk.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions from customers or changes to business or employee relationships could arise from the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price may occur before closing.
• General economic and market conditions, interest and exchange rates, monetary policy, and changes in laws and regulations and their enforcement could affect future results.
• Other unknown or unpredictable factors could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The outlook and expectations of Strive and Semler Scientific include the strategic and financial benefits of the proposed transaction, the expected impact on the combined company's future financial performance, the timing of the closing, and the ability to successfully integrate the combined businesses.

Management Comments

• Pierre Rochard, Board Member of Strive, Inc., reposted the communication on X.com on September 25, 2025, in connection with the proposed business combination.

Industry Context

The filing indicates that the combined company may pursue or expand Bitcoin treasury strategies and engage with other digital assets, a trend adopted by some companies seeking alternative asset management or strategic diversification. This suggests a potential shift or expansion for Semler Scientific, a medical device company, into areas related to digital asset management, aligning with Strive's apparent focus.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock.
• Stockholders of Semler Scientific will need to make a voting or investment decision regarding the proposed transaction.
• Customers of both Strive and Semler Scientific may have adverse reactions or experience changes to business relationships.
• Employees of both companies may experience changes to their relationships with the combined entity.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific.
• Semler Scientific stockholders will be asked to approve the proposed transaction.

Key Dates

Keywords

Strive Inc, Semler Scientific, Merger, Acquisition, Business Combination, SEC Filing, Form 425, Bitcoin Treasury Strategy, Digital Assets